Segmentation by type classifies Ketogenic Supplements into exogenous ketone salts, ketone esters, medium‑chain triglyceride (MCT) oils, and blended formulations. Exogenous ketone salts, the largest sub‑type with an estimated 45 % share, are favored for their lower cost and ease of manufacturing, though they introduce mineral load considerations. Ketone esters, contributing about 20 % of sales, deliver higher plasma β‑hydroxybutyrate levels and are primarily adopted by elite athletes and clinical trials despite higher pricing. MCT oils, encompassing roughly 25 % of the market, serve both as standalone energy sources and as carrier matrices for other ketone forms, supporting broader consumer acceptance. Blended formulations—combining salts, esters, and MCTs—account for the remaining 10 % and target niche segments seeking synergistic effects. This type‑based taxonomy clarifies product‑development pathways and informs supply‑chain allocation, as each sub‑type imposes unique raw‑material, stability, and regulatory requirements that collectively shape the market’s structural composition.